Summary
Suitable antimicrobials given during the catarrhal stage of whooping cough can attenuate the course of the disease. The efficacy of antibiotics administered prophylactically during the incubation period remains controversial but appears to be beneficial. Currently, erythromycin given for two weeks is the antibiotic of choice for pertussis. No treatment failures were observed with erythromycin estolate. Erythromycin ethylsuccinate and stearate must be given at high dosages (50–60 mg/kg/day) in order to achieve sufficient concentrations in the respiratory secretions. With ampicillin and amoxicillin treatment failures have been observed. The role of josamycin and co-trimoxazole in pertussis remains open.
Zusammenfassung
Geeignete Antibiotika können den Verlauf des Keuchhustens abschwächen, wenn sie während des Stadium catarrhale gegeben werden. Die Wirksamkeit einer prophylaktischen Antibiotikum-Gabe während der Inkubationszeit bleibt umstritten, scheint jedoch von Nutzen zu sein. Derzeit ist Erythromycin, für zwei Wochen gegeben, das Antibiotikum der Wahl. Bei Gabe von Erythromycin-Estolat sind keine Therapieversager beobachtet worden. Erythromycin-Äthylsuccinat und -Stearat müssen hoch dosiert werden (50–60 mg/kg/Tag), um ausreichende Konzentrationen in den Atemwegssekreten zu erzielen. Bei Gabe von Ampicillin und Amoxicillin sind Therapieversager beobachtet worden. Die Rolle von Josamycin und Co-trimoxazol beim Keuchhusten ist noch nicht geklärt.
Similar content being viewed by others
Literature
Lambert, H. Antimicrobial drugs in the treatment and prevention of pertussis. J. Antimicrob. Chemother. 5 (1979) 329–331.
Nelson, J. D. Antibiotic treatment of pertussis. Pediatrics 44 (1969) 474–476.
Hoppe, J. E., Haug, A.: Antimicrobial susceptibility ofBordetella pertussis. Infection, in press.
Field, L. H., Parker, C. D. Antibiotic susceptibility testing ofBordetella pertussis. Am. J. Clin. Pathol. 74 (1980) 312–316.
Smith, B. R., Le Frock, J. L. Bronchial tree penetration of antibiotics. Chest 83 (1983) 904–908.
Trollfors, B. Whooping cough-aspects of pathogenesis and treatment. Acta Otolaryngol. (Stockh.) Suppl. 407 (1984) 33–39.
Bass, J. W. Pertussis: current status of prevention and treatment. Pediatr. Infect. Dis. 4 (1985) 614–619.
Kwantes, W., Joynson, D. H. M., Williams, W. O. Bordetella pertussis isolation in general practice: 1977–1979 whooping cough epidemic in West Glamorgan. J. Hyg. (Camb.) 90 (1983) 149–158.
Medical Research Council Treatment of whooping cough with antibiotics. Lancet I (1953) 1109–1112.
Adcock, K. J., Reddy, S., Okubadejo, O. A., Montefiore, D. Trimethoprim/sulphamethoxazole in pertussis: comparison with tetracycline. Arch. Dis. Child. 47 (1972) 311–313.
Bass, J. W., Klenk, E. L., Kotheimer, J. B., Linnemann, C. C., Smith, M. H. D. Antimicrobial treatment of pertussis. J. Pediatr. 75 (1969) 768–781.
Strangert, K. Comparison between the effect of chloramphenicol and ampicillin in whooping cough. Scand. J. Infect. Dis. 1 (1969) 67–70.
Bass, J. W. Erythromycin for treatment and prevention of pertussis. Pediatr. Infect. Dis. 5 (1986) 154–157.
Islur, J., Anglin, C. S., Middleton, P. J. The whooping cough syndrome: a continuing pediatric problem. Clin. Pediatr. 14 (1975) 171–176.
Henry, R. L., Dorman, D. C., Skinner, J. A., Mellis, C. M. Antimicrobial therapy in whooping cough. Med. J. Aust. 2 (1981) 27–28.
Trollfors, B. Effect of erythromycin and amoxycillin onBordetella pertussis in the nasopharynx. Infection 6 (1978) 228–230.
Baraff, L. J., Wilkins, J., Wehrle, P. F. The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics 61 (1978) 224–230.
Bergquist, S. O., Bernander, S., Dahnsjö, H., Sundelöf, B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr. Infect. Dis. 6 (1987) 458–461.
Henry, R. L., Dorman, D. C., Skinner, J. A., Mellis, C. M. Limitations of erythromycin in whooping cough. Med. J. Aust. 2 (1981) 108–109.
McCracken, G. H., Ginsburg, C. M., Clahsen, J. C., Thomas, M. L. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics 62 (1975) 738–743.
Eriksson, M., Bolme, P., Blennow, M. Absorption of erythromycin from pediatric suspension in infants and children. Scand. J. Infect. Dis. 13 (1981) 211–215.
Halsey, N. A., Welling, M. A., Lehman, R. M. Nosocomial pertussis: a failure of erythromycin treatment and prophylaxis. Am. J. Dis. Child. 134 (1980) 521–522.
Ginsburg, C. M. Pharmacology of erythromycin in infants and children. Pediatr. Infect. Dis. 5 (1986) 124–129.
Dette, G. A. Vergleich der Gewebegängigkeit von Erythromycin. Infection 7 (1979) 129–145.
Eichenwald, H. F. Adverse reactions to erythromycin. Pediatr. Infect. Dis. 5 (1986) 147–150.
Broomhall, J., Herxheimer, A. Treatment of whooping cough: the facts. Arch. Dis. Child. 59 (1984) 185–187.
Altemeier, W. A., Ayoub, E. M. Erythromycin prophylaxis for pertussis. Pediatrics 59 (1977) 623–625.
Linnemann, C. C., Ramundo, N., Perlstein, P. H., Minton, S. D., Englender, G. S., McCormick, J. B., Hayes, P. S. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet II (1975) 540–543.
Grob, P. R. Prophylactic erythromycin for whooping cough contacts. Lancet I (1981) 772.
Spencely, M., Lambert, H. P. Prophylactic erythromycin for whooping cough contacts. Lancet I (1981) 772–773.
Torre, D., Maggiolo, F., Sampietro, C. Comparative clinical study of josamycin and erythromycin in pertussis. Chemioterapia 3 (1984) 255–257.
Schreinert, B. Josamycin — ein neues Makrolid-Antibiotikum. Klinische Erfahrungen in der Pädiatrie. Extracta Medica Practica 6, Suppl. 1 (1985) 59–62.
Waßmer, B., Riedl-Seifert, R. Hals-Nasen-Ohren-Infekte bei älteren Kindern: ein Vergleich zwischen Josamycin und Erythromycin. Sozialpädiatrie 9 (1987) 89–90.
Cascio, G., Titone, L., Portelli, V., Castello, G. Josamycin bei Streptokokkeninfektionen und Pertussis. Extracta Paediatrica 8, Suppl. 1 (1984) 47–52.
Simon, C., Bontemps, M., Wiese, K., Schewior-Roland, R. Zur Ampicillin-Therapie des Keuchhustens. Dtsch. Med. Wochenschr. 94 (1969) 2435–2437.
Feigin, R. D. Pertussis (whooping cough). In:Nelson, W. E., Behrman, R. E., Vaughan, V. C. (eds.): Textbook of pediatrics. W. B. Saunders, Philadelphia 1983, pp. 658–661.
Hughes, D. T. D., Bye, A., Hodder, P. Levels of trimethoprim and sulphamethoxazole in blood and sputum in relation to treatment of chest infections. In:Hejzlar, M., Semonsky, M., Masak, S. (eds.): Advances in antimicrobial and antineoplastic chemotherapy I/2. Urban & Schwarzenberg, München 1972, pp. 1105–1106.
Cullen, A. S., Cullen, H. B. Whooping cough: prophylaxis with cotrimoxazole. Lancet I (1978) 556.
Arneil, G. C., McAllister, T. A. Whooping cough in infants: antimicrobial prophylaxis? Lancet II (1977) 33–34.
Arneil, G. C., McAllister, T. A. Prevention of whooping cough by antibiotics. Practitioner 219 (1977) 855–858.
Rabo, E. Drug prophylaxis in pertussis. Lancet II (1977) 707–708.
Nakazawa, S., Sato, H., Niino, K., Nakazawa, S. I., Suzuki, H., Iwasaki, A., Chikaoka, H., Hirama, Y., Narita, A. Treatment of pertussis with cefoperazone. Jap. J. Antibiot. 33 (1980) 865–870.
Motohiro, T., Sakata, Y., Fujimoto, T., Nishiyama, T., Nakajima, T., Ishimoto, K., Tominaga, K., Yamashita, F., Shishido, H., Watanabe, K., Matsumoto, K., Tazaki, K., Oki, S., Araki, H., Takajo, N., Yuasa, K., Tanaka, Y., Tsugawa, S., Nagayama, K., Komatsu, R., Yamamoto, M., Ookita, R., Sakaguchi, Y., Terasawa, K., Kinoshita, M. Treatment of whooping cough and whooping cough syndrome by cefoperazone. Jap. J. Antibiot. 33 (1980) 1183–1193.
Minamitani, M., Hachimori, K., Nakazawa, S., Sato, H., Narita, A., Hirama, Y., Nakazawa, S. I., Chikaoka, H., Motohiro, T., Nishiyama, T., Fujimoto, T., Ishimoto, K., Tominaga, K., Yamashita, F., Matsuo, H., Koga, Y., Eto, Y., Matsuyuki, M., Yuasa, T., Tanaka, Y., Nagayama, K., Shimada, Y., Aramaki, S., Takajo, N., Araki, H., Kowano, Y. Clinical results of latamoxef on pertussis. Jap. J. Antibiot. 36 (1983) 233–240.
Aufrant, C., Lambert-Zechovsky, N., Aujard, Y., Bingen, E., Blum, C., Beaufils, F., Mathieu, H. Le céfotaxime dans les infections à bacille Gram négatif de l'enfant. Nouv. Presse Méd. 10 (1981) 639–646.
Garnier, J. M., Giraud, F. Utilisation du céfotaxime dans les maladies infectieuses de l'enfant. Nouv. Presse Méd. 10 (1981) 629–633.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoppe, J.E., Haug, A. Treatment and prevention of pertussis by antimicrobial agents (Part II). Infection 16, 148–152 (1988). https://doi.org/10.1007/BF01644089
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01644089